123 related articles for article (PubMed ID: 2441529)
21. [Transcapillary filtration of plasma proteins in patients with diabetes type II microangiopathy complications].
Muszyńska-Lachota I
Ann Acad Med Stetin; 2002; 48():255-69. PubMed ID: 14601482
[TBL] [Abstract][Full Text] [Related]
22. Advanced glycation end products in adolescents and young adults with diabetic angiopathy.
Chiarelli F; Catino M; Tumini S; Cipollone F; Mezzetti A; Vanelli M; Verrotti A
Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941
[TBL] [Abstract][Full Text] [Related]
23. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.
Sjølie AK; Stephenson J; Aldington S; Kohner E; Janka H; Stevens L; Fuller J
Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629
[TBL] [Abstract][Full Text] [Related]
24. Effect of dihydroergotamine on coagulation factors and components of the fibrinolytic system.
Svanberg L; Bernstein K; Kullander S; Astedt B
Acta Obstet Gynecol Scand; 1980; 59(3):251-3. PubMed ID: 6158827
[TBL] [Abstract][Full Text] [Related]
25. Implications for glucose measures in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
Whaley-Connell A; Sowers JR
Diabetes; 2014 Jan; 63(1):45-7. PubMed ID: 24357694
[No Abstract] [Full Text] [Related]
26. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.
Davis MD; Fisher MR; Gangnon RE; Barton F; Aiello LM; Chew EY; Ferris FL; Knatterud GL
Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):233-52. PubMed ID: 9477980
[TBL] [Abstract][Full Text] [Related]
27. Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes - A prospective cohort study.
Dai D; Shen Y; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J
J Diabetes Complications; 2021 Sep; 35(9):107971. PubMed ID: 34187717
[TBL] [Abstract][Full Text] [Related]
28. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
Wang N; Xu Z; Han P; Li T
Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
[TBL] [Abstract][Full Text] [Related]
29. Glycosylated albumin and glycosylated proteins: rapidly changing indices of glycaemia in diabetic pregnancy.
Leiper JM; Talwar D; Robb DA; Lunan CB; MacCuish AC
Q J Med; 1985 Jun; 55(218):225-31. PubMed ID: 4023170
[TBL] [Abstract][Full Text] [Related]
30. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
Davis TM; Moore JC; Turner RC
Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
[TBL] [Abstract][Full Text] [Related]
31. [Relation of diabetic markers and tumor markers--hemoglobin A1, glycosylated albumin, glycosylated protein and CEA, CA19-9 in diabetic and cancerous patients].
Maruyama S
Rinsho Byori; 1985 Nov; 33(11):1306-12. PubMed ID: 3867765
[No Abstract] [Full Text] [Related]
32. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
Aso Y; Inukai T; Tayama K; Takemura Y
Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
[TBL] [Abstract][Full Text] [Related]
33. [Hemorheologic and coagulation study in a group of patients with diabetic retinopathy].
Parenti M; Pasquali R; Sorrenti G; Babini AC; Melchionda N; Palareti G; Poggi M; Tricarico G
G Clin Med; 1984; 65(9-10):409-18. PubMed ID: 6442246
[No Abstract] [Full Text] [Related]
34. 15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period).
Koert M; Nowak-Göttl U; Kreuz W; Grüttner HP; Kornhuber B; Breddin HK
Klin Padiatr; 1991; 203(6):429-32. PubMed ID: 1721940
[TBL] [Abstract][Full Text] [Related]
35. Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy.
Loho T; Venna V; Setiabudy RD; Sukartini N; Immanuel S; Kumalawati J; Victor AA; Waspadji S
Acta Med Indones; 2018 Apr; 50(2):132-137. PubMed ID: 29950532
[TBL] [Abstract][Full Text] [Related]
36. Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus.
Fosmark DS; Torjesen PA; Kilhovd BK; Berg TJ; Sandvik L; Hanssen KF; Agardh CD; Agardh E
Metabolism; 2006 Feb; 55(2):232-6. PubMed ID: 16423631
[TBL] [Abstract][Full Text] [Related]
37. Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia.
Cefalu WT; Wang ZQ; Bell-Farrow A; Kiger FD; Izlar C
Clin Chem; 1994 Jul; 40(7 Pt 1):1317-21. PubMed ID: 8013106
[TBL] [Abstract][Full Text] [Related]
38. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study.
Nathan DM; McGee P; Steffes MW; Lachin JM;
Diabetes; 2014 Jan; 63(1):282-90. PubMed ID: 23990364
[TBL] [Abstract][Full Text] [Related]
39. The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy.
Jennings PE; McLaren M; Scott NA; Saniabadi AR; Belch JJ
Diabet Med; 1991 Nov; 8(9):860-5. PubMed ID: 1837513
[TBL] [Abstract][Full Text] [Related]
40. Glycated albumin indicates peripheral diabetic neuropathy.
Wang N; Guo C; Han P; Li T
Acta Diabetol; 2016 Dec; 53(6):973-979. PubMed ID: 27573202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
